| MESOBLAST LTD. |
| Australien |
| Gesundheit |
| AU000000MSB8 / A0DNPW |
| LWB (Frankfurt) |
| FRA:LWB, ETR:LWB, LWB:GR |
| - |
| https://www.mesoblast.com.. |
|
Mesoblast Limited is a biotechnology company specializing in the development of allogeneic, or off-the-shelf, cellular medicines intended for the treatment of severe and life-threatening inflammatory conditions. Leveraging a proprietary technology pl..
>Volltext.. |
| 1866.01 Mio. EUR |
| 1870.43 Mio. EUR |
| 58.93 Mio. EUR |
| -58.79 Mio. EUR |
| -86.06 Mio. EUR |
| -0.07 EUR |
| 118.85 Mio. EUR |
| 114.3 Mio. EUR |
| -64.5 Mio. EUR |
| 1.01 |
| 1011.51% |
| 10.99% |
| - |
| - |
| - |
| - |
| MESOBLAST |
| 25.07.26 |
|